277 related articles for article (PubMed ID: 15896352)
1. Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder.
Barkley RA; Murphy KR; O'Connell T; Connor DF
J Safety Res; 2005; 36(2):121-31. PubMed ID: 15896352
[TBL] [Abstract][Full Text] [Related]
2. Effects of two doses of alcohol on simulator driving performance in adults with attention-deficit/hyperactivity disorder.
Barkley RA; Murphy KR; O'Connell T; Anderson D; Connor DF
Neuropsychology; 2006 Jan; 20(1):77-87. PubMed ID: 16460224
[TBL] [Abstract][Full Text] [Related]
3. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
4. Impact of methylphenidate delivery profiles on driving performance of adolescents with attention-deficit/hyperactivity disorder: a pilot study.
Cox DJ; Merkel RL; Penberthy JK; Kovatchev B; Hankin CS
J Am Acad Child Adolesc Psychiatry; 2004 Mar; 43(3):269-75. PubMed ID: 15076259
[TBL] [Abstract][Full Text] [Related]
5. A pilot study of the effects of atomoxetine on driving performance in adults with ADHD.
Barkley RA; Anderson DL; Kruesi M
J Atten Disord; 2007 Feb; 10(3):306-16. PubMed ID: 17242426
[TBL] [Abstract][Full Text] [Related]
6. Driving impairments in teens and adults with attention-deficit/hyperactivity disorder.
Barkley RA
Psychiatr Clin North Am; 2004 Jun; 27(2):233-60. PubMed ID: 15063996
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
8. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
9. Methylphenidate significantly improves driving performance of adults with attention-deficit hyperactivity disorder: a randomized crossover trial.
Verster JC; Bekker EM; de Roos M; Minova A; Eijken EJ; Kooij JJ; Buitelaar JK; Kenemans JL; Verbaten MN; Olivier B; Volkerts ER
J Psychopharmacol; 2008 May; 22(3):230-7. PubMed ID: 18308788
[TBL] [Abstract][Full Text] [Related]
10. Hyperactive children as young adults: driving abilities, safe driving behavior, and adverse driving outcomes.
Fischer M; Barkley RA; Smallish L; Fletcher K
Accid Anal Prev; 2007 Jan; 39(1):94-105. PubMed ID: 16919226
[TBL] [Abstract][Full Text] [Related]
11. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
Medori R; Ramos-Quiroga JA; Casas M; Kooij JJ; Niemelä A; Trott GE; Lee E; Buitelaar JK
Biol Psychiatry; 2008 May; 63(10):981-9. PubMed ID: 18206857
[TBL] [Abstract][Full Text] [Related]
12. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
Bush G; Spencer TJ; Holmes J; Shin LM; Valera EM; Seidman LJ; Makris N; Surman C; Aleardi M; Mick E; Biederman J
Arch Gen Psychiatry; 2008 Jan; 65(1):102-14. PubMed ID: 18180434
[TBL] [Abstract][Full Text] [Related]
13. Long-acting methylphenidate reduces collision rates of young adult drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Davis M; Mikami AY; Singh H; Merkel RL; Burket R
J Clin Psychopharmacol; 2012 Apr; 32(2):225-30. PubMed ID: 22367664
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
15. Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD.
Pearson DA; Santos CW; Casat CD; Lane DM; Jerger SW; Roache JD; Loveland KA; Lachar D; Faria LP; Payne CD; Cleveland LA
J Am Acad Child Adolesc Psychiatry; 2004 Jun; 43(6):677-85. PubMed ID: 15167084
[TBL] [Abstract][Full Text] [Related]
16. The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder.
Coghill DR; Rhodes SM; Matthews K
Biol Psychiatry; 2007 Nov; 62(9):954-62. PubMed ID: 17543895
[TBL] [Abstract][Full Text] [Related]
17. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
Fallu A; Richard C; Prinzo R; Binder C
Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
[TBL] [Abstract][Full Text] [Related]
18. Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder.
Barkley RA; Murphy KR; Kwasnik D
Pediatrics; 1996 Dec; 98(6 Pt 1):1089-95. PubMed ID: 8951258
[TBL] [Abstract][Full Text] [Related]
19. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
[TBL] [Abstract][Full Text] [Related]
20. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence.
Smith BH; Pelham WE; Gnagy E; Yudell RS
J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):314-21. PubMed ID: 9519637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
